A CC-type chemokine that is specific for CCR3 RECEPTORS. It is a potent chemoattractant for EOSINOPHILS.
Chemokine Ccl11 has been studied across 21 research domains including 🔬 Inflammation, 🛡️ Immunity, 🫁 Respiratory, ⏳ Longevity & Aging, 🔬 Oncology. The primary research focus is 🔬 Inflammation with 36% of studies addressing this area.
This evidence profile for Chemokine Ccl11 is generated deterministically from 55 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.